Gilead's COVID-19 hopeful remdesivir may get swift Japanese approval: report

Gilead's COVID-19 hopeful remdesivir may get swift Japanese approval: report

Source: 
Fierce Biotech
snippet: 

Japanese Prime Minister Shinzo Abe is set to grant Gilead Sciences' experimental COVID-19 drug remdesivir a special, speedy approval, despite it failing to show any definitive clinical signs that it works.